fr 110302 has been researched along with ozone in 1 studies
| Studies (fr 110302) | Trials (fr 110302) | Recent Studies (post-2010) (fr 110302) | Studies (ozone) | Trials (ozone) | Recent Studies (post-2010) (ozone) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 16,569 | 425 | 7,212 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asano, M; Hiroi, J; Imai, T; Inamura, N; Inoue, H; Masunaga, T; Nakahara, K; Notsu, Y; Takishima, T; Yatabe, T | 1 |
1 other study(ies) available for fr 110302 and ozone
| Article | Year |
|---|---|
A 5-lipoxygenase inhibitor, FR110302, inhibits ozone-induced airway hyperresponsiveness in guinea pigs and dogs.
Topics: Acetylcholine; Administration, Oral; Airway Resistance; Animals; Bronchial Hyperreactivity; Dogs; Guinea Pigs; Lipoxygenase Inhibitors; Naphthols; Ozone; Quinolines | 1993 |